Drug Pipeline

NX-5948 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
3
Recruiting
1
Phase 3
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-29 NCT07221500
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine…		 Trial sites expanded: 20 -> 24 locations
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07516093 Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL B-cell Lymphoma Not Yet Recruiting
Phase 2
NCT07221500 A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine… Chronic Lymphocytic Leukemia (CLL) Recruiting
Phase 1/2
NCT07520006 Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies B-cell Lymphoma Not Yet Recruiting
Phase 1
NCT06717269 Relative Bioavailability of NX-5948 Tablets vs Capsules and the Effect of Covariates on… Healthy Volunteer Recruiting
NCT05131022 A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies Chronic Lymphocytic Leukemia (CLL) Recruiting
Sponsors Running NX-5948 Trials
Nurix Therapeutics, Inc. (5)
Disease Areas
Leukemia (4) Chronic Lymphocytic Leukemia (CLL) (4) DLBCL (1) Follicular Lymphoma (1) Mantle Cell Lymphoma (1)
Get alerts when NX-5948 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free